Home Carboxes 1260664-81-0
1260664-81-0,MFCD18250166
Catalog No.:AA000QXW

1260664-81-0 | 6-Chloro-1h-pyrazolo[3,4-b]pyrazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$13.00   $9.00
- +
250mg
95%
in stock  
$19.00   $14.00
- +
500mg
95%
in stock  
$31.00   $22.00
- +
1g
95%
in stock  
$45.00   $32.00
- +
5g
95%
in stock  
$156.00   $109.00
- +
10g
95%
in stock  
$272.00   $191.00
- +
25g
95%
in stock  
$598.00   $419.00
- +
50g
95%
in stock  
$1,018.00   $713.00
- +
100g
95%
in stock  
$1,731.00   $1,212.00
- +
250g
95%
in stock  
$2,940.00   $2,058.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000QXW
Chemical Name:
6-Chloro-1h-pyrazolo[3,4-b]pyrazine
CAS Number:
1260664-81-0
Molecular Formula:
C5H3ClN4
Molecular Weight:
154.5571
MDL Number:
MFCD18250166
SMILES:
Clc1cnc2c(n1)[nH]nc2
Properties
Computed Properties
 
Complexity:
131  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
XLogP3:
0.8  

Downstream Synthesis Route

[1]CurrentPatentAssignee:RELAYTHERAPEUTICSINC-WO2018/81091,2018,A1Locationinpatent:Paragraph0127;0128;0133

[2]CurrentPatentAssignee:D.E.SHAWRESEARCHLLC;RELAYTHERAPEUTICSINC-WO2019/183367,2019,A1Locationinpatent:Paragraph0167

[3]CurrentPatentAssignee:CNCCSSCARLCOLLEZIONENAZDEICOMPOSTICH;ISTITUTODIRICERCHEDIBIOLOGIAMOLECOLAREP.ANGELETTIS.R.L.-WO2022/167682,2022,A1Locationinpatent:Page/Pagecolumn174

[4]CurrentPatentAssignee:RELAYTHERAPEUTICSINC-WO2018/57884,2018,A1Locationinpatent:Paragraph0234

[5]CurrentPatentAssignee:ZHENGZHOUUNIVERSITY-CN114213417,2022,ALocationinpatent:Paragraph0161-0165

[6]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-US2021/85677,2021,A1Locationinpatent:Paragraph0177;0195-0196

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2020/249802,2020,A1Locationinpatent:Page/Pagecolumn51

[2]CurrentPatentAssignee:D.E.SHAWRESEARCHLLC;RELAYTHERAPEUTICSINC-WO2019/183367,2019,A1Locationinpatent:Paragraph0166

[3]CurrentPatentAssignee:RELAYTHERAPEUTICSINC-WO2018/81091,2018,A1Locationinpatent:Paragraph0127;0128;0132

[4]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-US2021/85677,2021,A1

[5]CurrentPatentAssignee:CNCCSSCARLCOLLEZIONENAZDEICOMPOSTICH;ISTITUTODIRICERCHEDIBIOLOGIAMOLECOLAREP.ANGELETTIS.R.L.-WO2022/167682,2022,A1Locationinpatent:Page/Pagecolumn185

[1]CurrentPatentAssignee:ZHENGZHOUUNIVERSITY-CN114213417,2022,ALocationinpatent:Paragraph0145-0150

[2]Bagdanoff,JeffreyT.;Chen,Zhouliang;Acker,Michael;Chen,Ying-Nan;Chan,Homan;Dore,Michael;Firestone,Brant;Fodor,Michelle;Fortanet,Jorge;Hentemann,Murphy;Kato,Mitsunori;Koenig,Robert;Labonte,LauraR.;Liu,Shumei;Mohseni,Movarid;Ntaganda,Rukundo;Sarver,Patrick;Smith,Troy;Sendzik,Martin;Stams,Travis;Spence,Stan;Towler,Christopher;Wang,Hongyun;Wang,Ping;Williams,SarahL.;Lamarche,MatthewJ.[JournalofMedicinalChemistry,2019,vol.62,#4,p.1781-1792]

[1]CurrentPatentAssignee:D.E.SHAWRESEARCHLLC;RELAYTHERAPEUTICSINC-WO2019/183367,2019,A1

6-chloro-1H-pyrazolo3,4-bpyrazine 
  74-88-4    1539296-65-5 

[1]CurrentPatentAssignee:GB002-WO2020/264420,2020,A1Locationinpatent:Page/Pagecolumn186

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1260664-81-0 Molecular Formula|1260664-81-0 MDL|1260664-81-0 SMILES|1260664-81-0 6-Chloro-1h-pyrazolo[3,4-b]pyrazine |Heterocyclic_Building_Blocks